Mangalam Organics Limited has informed the Exchange regarding 'Investor Presentation for the fourth quarter and year ended March 31, 2025'.
MANORG · price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Mangalam Organics, a 1946-founded player in pine chemistry (camphor, terpenes, resins), reported FY25 consolidated revenue of Rs. 530.01 Cr, up 7.39% YoY. Profitability improved sharply with EBITDA at Rs. 58.58 Cr (+51.49%) and PAT at Rs. 12.50 Cr (+196.91%), driven by lower input costs. EBITDA margin expanded by 321 basis points to 11.05%, while PAT margin rose to 2.36% from 0.85%. Q4 FY25 was even stronger with revenue of Rs. 149.79 Cr (+42.52%), EBITDA of Rs. 19.67 Cr (+92.47%), and PAT of Rs. 5.08 Cr (+107.35%). The company is pursuing B2C growth via CamPure brand and e-commerce (pin codes serviced grew from 9,000 in FY20 to 21,000+ in FY25) while B2B continues to focus on unlocking intermediate value beyond camphor.
Strong Q4 and full-year earnings beat with significant margin expansion is a positive signal for shareholders, supported by management's explicit commitment to further efficiency and margin improvements. However, rising borrowings (Rs. 269 Cr vs Rs. 172 Cr) and negative operating cash flow (-Rs. 7.84 Cr) due to working capital build-up are points to watch.